Patent ID: 9547010
Date: 2017-01-17
CPC Classifications: C07K,G01N

Claim:
1. A method for the immunological quantification of an anti-amyloid β peptide (anti-Aβ) antibody in a sample, the method comprising the steps of: providing an immunoassay comprising an antibody obtained from cell line DSM ACC2939, wherein said immunoassay comprises a capture antibody, a tracer antibody and a detection antibody, said tracer antibody is conjugated to a detectable label, wherein at least one of the capture antibody and the tracer antibody is the antibody obtained from cell line DSM ACC2939; simultaneously or sequentially incubating the capture antibody and the tracer antibody with the sample to form a (capture antibody)-(anti-Aβantibody)-(tracer antibody) complex; incubating the (capture antibody)-(anti-Aβantibody)-(tracer antibody) complex with the detection antibody, wherein said detection antibody is directed against the detectable label conjugated to the tracer antibody; and quantifying the amount of said anti-Aβantibody in the sample by determining the presence of the detectable label of the tracer antibody.